Vanguard Capital Management
MED icon

Vanguard Capital Management’s Medifast MED Stock Holding History

Vanguard Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74M Buy
446,614
+2,147
+0.5% +$24.8K ﹤0.01% 3143
2026
Q1 		$4.53M Buy
+444,467
New +$4.79M ﹤0.01% 3102

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management's MED Position: Q2 2026 in Review

Vanguard Capital Management increased its Medifast (MED) stake by 0.48% in Q2 2026, buying an estimated $24.8K and bringing the position to 446,614 shares worth $4.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3143.

Vanguard Capital Management first reported a position in MED in Q1 2026 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Vanguard Capital Management held 446,614 shares of Medifast worth $4.74M as of Q2 2026.
  • Vanguard Capital Management bought 2,147 Medifast shares in Q2 2026, an estimated $24.8K.
  • Medifast made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3143 holding.
  • Vanguard Capital Management first reported a position in Medifast in Q1 2026 and has held it in 2 quarters since.
  • 109 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.